Additionally, preclinical ALS studies reported delays in symptom onset and improved survival in a SOD1G93A mouse model with lifelong AAV-IL-10 overexpression in the spinal cord [36,37]. Here, IL10 is linked to amyotrophic lateral sclerosis.